Kavita Jain

Kavita Jain

Auto-generated profile, based on publicly available information

Kavita Jain

Department of Pathology, R.D. Gardi Medical College, Ujjain, India

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Sage Open Medicine
Verified
Journal Article
Open access
KJKavita Jain
Kavita Jain
ASAkshay Surana
Akshay Surana
TCTej Singh Choudhary
Tej Singh Choudhary
SVSudhakar Vaidya
Sudhakar Vaidya
SNShirish Nandedkar
Shirish Nandedkar
MPManju Purohit
Manju Purohit
Background: An upsurge in cases of rhinosinusitis with or without associated orbital and/or cerebral involvement by mucormycosis has been observed in post-COVID-19 patients. Our objective is to evaluate the clinical and histopathology features of these patients to determine the severity and develop a scoring on the extent on tissue invasion. Method: We prospectively enrolled and analyzed 95 post-COVID-19 patients who presented with the invasive mucormycosis of the head and neck region. Clinical and histology details were noted in predesigned forms. Various histology variables were graded from I to III to propose a scoring system for the severity of the disease. Results: Mucormycosis was common in males with a mean age of 46.8 ± 11 years. Facial pain was the most common presenting complaint and 77% of the patients were diabetic. Most cases (n = 59) showed a moderate degree of neutrophilic infiltrate with ⩾50% tissue necrosis and angioinvasion in three or more vessels with a fungal load of 2+/3+. Histology severity grade III was observed in patients who died from cerebral mucormycosis (n = 3) and septicemia (n = 2) and in patients who had undergone orbital exenteration (n = 6). Conclusion: The histopathology and severity score classification was directly correlated with the outcome of the patients. Further evaluation and a larger study will help to validate the proposed scoring for its clinical use in all forms and causes of mucormycosis.

1 January 2022 in Clinical Pathology
Verified
Journal Article
Open access
KJKavita Jain
Kavita Jain
DSDarshita Sharma
Darshita Sharma
MPMala Patidar
Mala Patidar
SNShirish Nandedkar
Shirish Nandedkar
Ashish PathakAshish Pathak
Ashish Pathak
MPManju Purohit
Manju Purohit
Introduction: Early diagnosis of sepsis and its severity is essential for appropriate treatment to improve patient survival, especially in resource-limited settings. The aim of the present study was to study the role of red blood cell distribution (RDW) as a biomarker for the early detection of severe sepsis defined clinically and also in the prediction of mortality from sepsis. Methods: The cross-sectional study included a total of 175 subjects who met the inclusion criteria for the diagnosis of severe sepsis. After a thorough clinical examination, blood samples were taken from all patients within 3 hours of presenting the disease. The RDW values and other investigations were studied on the day of admission compared to other severity markers with the mortality index of 30 days. Result: The RDW value was significantly higher in patients with severe sepsis and in non-survivor patients than in survivors ( P < .0001). There was a strong correlation between the SOFA score and RDW in predicting the disease outcome with the Pearson correlation coefficient of r = .46. The area under the receiver operating characteristic curve was found to be 0.852 at a CI of 95% (0.796-0.909) with RDW 17.15, sensitivity was 88.6% and specificity was 63.5%. There was a positive correlation with Pearson’s correlation coefficient of r = .46 between RDW and the SOFA score. Conclusions: RDW can be used as a potential marker for the early detection of severe sepsis and in the prediction of the outcome. Large multicenter prospective studies can confirm the utility of this routinely available marker for patients with sepsis.

3 April 2023 in Indian Journal of Cancer
Verified
Journal Article
Open access
KJKavita Jain
Kavita Jain
KBkarthik Bommannan
karthik Bommannan
PGPrasanth Ganesan
Prasanth Ganesan
JAJhansi Rani Arumugam
Jhansi Rani Arumugam
TSTenali Gnana Sagar
Tenali Gnana Sagar
SSShirley Sundersingh
Shirley Sundersingh
Background: Multiple myeloma (MM) results from clonal expansion of immunoglobulin secreting, heavy chain class-switched, terminally differentiated B-lymphocytes (plasma cells), resulting in radiologic or biochemical evidence of end-organ damage. Though neurological manifestations (peripheral neuropathies, spinal radiculopathies, cranial nerve palsies, and metabolic encephalopathies) can occur during the disease course, direct central nervous system (CNS) infiltration by malignant plasma cells (CNS-MM) is very rare (~1%) and has a dismal prognosis (survival of <6 months). Methodology: Clinico-laboratory profile and outcome of CNS-MM patients diagnosed and treated at a tertiary cancer care hospital were retrospectively analyzed. Results: On scrutinizing 500 consecutive myeloma case records, 4 patients with CNS-MM were identified. All these patients were diagnosed during myeloma relapse, and all had deceased within 1 week and 12 months of developing CNS infiltration. Our experience with CNS-MM patients is similar to the experiences documented across major world literature. Conclusion: Our manuscript reinforces that CNS-MM should be considered in any myeloma patient presenting with unexplainable CNS manifestations. As there are no prospective studies to recommend optimal treatment strategies, CNS-MM still remains a dismal complication of myeloma.

1 January 2016 in International Journal of Research in Medical Sciences
Verified
Journal Article
Open access
AKArvind Khare
Arvind Khare
VMVeena Mathur
Veena Mathur
KJKavita Jain
Kavita Jain
SSSurendra Sethi
Surendra Sethi
DGDeepak Garg
Deepak Garg
RVRaghunath Vishnoi
Raghunath Vishnoi

15 May 2023 in Central India Journal of Medical Research
Verified
Journal Article
Open access
PDF file
KJKavita Jain
Kavita Jain
NPNitin Patel
Nitin Patel
Suprarenal mass with hypertension points towards endocrine etiology like phaeochromocytoma, primary aldosteronism and cushing’s disease. Here we report a 50 year old female who presented with adrenal mass and hypertension. On radiology and histopathology, she was reported as having benign adrenal myelolipoma. Her pre-operative and post-operative vanillylmandelic acid in 24 hrs urine were within normal limits. Rarely adrenal myelolipoma can be associated with catecholamine secretion. This case is reported here to highlight the importance of good clinical workup when faced with the diagnostic dilemma of a functional adrenal myelolipoma or pheochromocytoma as a differential to suprarenal mass associated with hypertension along with brief review of few rare case reports.

9 February 2023 in Central India Journal of Medical Research
Verified
Journal Article
Closed access
KJKavita Jain
Kavita Jain
PRP K Roy
P K Roy
Neuroendocrine neoplasms (NEN) are derived from endocrine cells and are very rarely seen in gynecological practice. Here we report a case of small cell neuroendocrine carcinoma (SCNEC) of cervix in a 45 year old married female who presented with history of menorrhagia. On gynecological examination, she had bulky uterus with a palpable non tender, hard nodule on posterior wall of cervix. Ultrasonogram of pelvis was reported as bulky ? adenomyotic uterus with 2.7x2.4x1.0cm well defined collection in fundal region of endometrium. She underwent total abdominal hysterectomy for abnormal uterine bleeding. Histopathology with immunohistochemical markers was reported as small cell neuroendocrine carcinoma (SCNEC) of cervix. This case is reported here for its rarity.